Carrie L. Bourdow

Insider Reports History

Entity
Individual
Location
C/O Trevena, Inc., 1018 West 8 Th Avenue, Suite A, King Of Prussia, PA
Signature
/s/ Jennifer Keyser, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrie L. Bourdow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TREVENA INC Acting CEO, Director Common Stock 23.9K $35.1K $1.47 Oct 8, 2024 Direct
Sesen Bio, Inc. Director Common Stock 40K $23.5K $0.59 Jun 22, 2022 Direct
Nabriva Therapeutics plc Director Ordinary Shares 9.93K $14.9K $1.50 Aug 1, 2022 Direct
Sesen Bio, Inc. Director Stock Option 65K Jun 22, 2022 Direct

Insider Reports Filed by Carrie L. Bourdow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVN TREVENA INC Oct 8, 2024 5 -$2.68K 4 Oct 10, 2024 Acting CEO, Director
TRVN TREVENA INC Dec 14, 2023 3 $282K 4 Dec 15, 2023 President & CEO
TRVN TREVENA INC Dec 2, 2023 3 -$7.1K 4 Dec 5, 2023 President & CEO
TRVN TREVENA INC Jan 6, 2023 1 $0 4 Jan 6, 2023 President & CEO, Director
TRVN TREVENA INC Dec 17, 2022 1 -$2.08K 4 Dec 20, 2022 President & CEO
TRVN TREVENA INC Dec 2, 2022 1 -$12.2K 4 Dec 6, 2022 President & CEO, Director
NBRV Nabriva Therapeutics plc Aug 1, 2022 1 -$1.49K 4 Aug 3, 2022 Director
CARM Sesen Bio, Inc. Jun 22, 2022 2 $0 4 Jun 24, 2022 Director
TRVN TREVENA INC Dec 17, 2021 1 -$23.5K 4 Dec 21, 2021 President & CEO, Director
TRVN TREVENA INC Dec 6, 2021 1 -$60.8K 4 Dec 8, 2021 President & CEO, Director
TRVN TREVENA INC Dec 2, 2021 1 $0 4 Dec 3, 2021 President & CEO, Director
NBRV Nabriva Therapeutics plc Aug 2, 2021 1 -$932 4 Aug 4, 2021 Director
NBRV Nabriva Therapeutics plc Jul 28, 2021 2 $0 4 Jul 30, 2021 Director
TRVN TREVENA INC Jun 28, 2021 1 $101K 4 Jun 28, 2021 President & CEO, Director